Michigan Veterinary Specialists
search MichVet.com:

Tumors of the Toes

 

Information For Pet Owners

< Back to Article Index

Key Points

Squamous cell carcinoma is most common digital tumor followed by melanoma

Squamous cell carcinomas have a low metastatic potential, whereas the melanomas have a much higher spread rate

Amputation of the toe is needed for digital tumors

The overall prognosis is favorable

 

What is it?

  • The most common tumors of the toes include the squamous cell carcinoma, melanoma, osteosarcoma, hemangiopericytoma, benign soft tissue tumors, and malignant soft tissue tumors
  • Squamous cell carcinoma
    • More than 50% of all digital tumors are squamous cell carcinoma.
    • originates from skin cells
    • very locally invasive
    • commonly destructive to the bone
  • Melanoma
    • second most common tumor and accounts for 16% of all digital tumors.
    • originate from the pigment-producing cells in the skin called melanocytes
    • nail bed melanomas spread rapidly to other areas of the body
    • at the time of diagnosis of a digital melanoma, detectable spread to the lungs is seen in one-third of all affected dogs


Signs

  • Breeds
    • Squamous cell carcinoma is most commonly seen in large breed dogs with black coats. Over-represented breeds include Labrador Retrievers and Standard Poodles.
  • Signs that the pet owner may see
    • swelling of the digit - initially it may appear like a toe infection
    • tumor may include appear black with some melanomas
    • loss of toenail
    • lameness
  • Additional signs that the veterinarian may note
    • enlargement of lymph nodes that drain the affected toe
  • Signs that may be seen if metastasis is present
    • breathing difficulty
    • coughing
    • weight loss
    • poor appetite
    • malaise

 

Diagnosis

  • Fine needle biopsy - involves only collecting a sample of cells with a needle
  • Tissue biopsy (wedge or core)
  • Complete blood count, chemistry profile, and urine testing are done to evaluate your companion’s internal organs prior to anesthesia and surgery
  • X-rays may show destruction of the bone of the digit, especially if the tumor is a squamous cell carcinoma
  • Chest x-rays and abdominal ultrasound are used to help rule out spread of the cancer
  • Lymph nodes in the area of the tumor are aspirated to rule out spread of the cancer to the nodes; regional lymph nodes may also be removed and analyzed to rule out cancer

 

Treatment

  • Surgery
    • surgical removal of the entire digit if a malignant tumor is present
    • benign tumors of the skin of the digits may be removed without removing the digit
  • Adjunctive therapy
    • chemotherapy or radiation) may be indicated for some malignant tumors. U
    • surgery is all that is needed typically for a squamous cell carcinoma
    • melanomas should be treated more aggressively with surgery, melanoma vaccination, chemotherapy and/or radiation
    • chemotherapy - one treatment is administered every 3 weeks for a total of 4 to 6 treatments. Most patients tolerate the chemotherapy medication with transient mild side effects
    • radiation therapy has been shown to prevent or delay the onset of tumor regrowth. Eighteen to 21 radiation treatments are administered to the tumor site and regional lymph nodes, starting 2 weeks after the tumor has been removed. Radiation treatments are administered Monday through Friday with no treatment during weekends. A short anesthesia is required during administration of each radiation treatment.

 

Homecare

  • Continue administration of prescribed pain-relieving medication
  • Keep the bandage on for 5 to 7 days
  • Incision - should be checked for signs of infection after the bandage has been removed
  • Diet - A low fat diet may be recommended in some patients; however, a regular diet may be tolerated.
  • Antibiotics - prescribed after the surgery if bacterial infection is suspected or confirmed by culture results
  • Exercise - restricted for about 3 weeks after surgery
  • Recheck evaluations
    • 2 weeks after surgery
    • chemotherapy is typically started 2 weeks after surgery
    • melanoma vaccination can be started as soon as the biopsy report has confirmed the diagnosis


Prognosis

  • Digital melanomas
    • median survival time of 365 days with amputation of digit alone
    • the melanoma vaccine can provide excellent long-term control of the disease and increased survival time. Minimal to no side effects are seen with the vaccination.
  • Squamous cell carcinoma
    • this tumor has a very good chance to be cured with surgery alone


Complications

  • Opening of the incision before it has healed
  • Infection
  • Tumor recurrence
  • Spread of cancer to other parts of the body
  • Ongoing lameness following amputation of the digit (rare)

 

References

  1. Henry CJ, et al. Canine digital tumors: a veterinary cooperative oncology group retrospective study of 64 dogs. J Vet Intern Med. 2005 Sept-Oct;19(5):720-4.

  2. Bergman PJ, et al. Development of xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine. 2006 May 22;24(21):4582-5.

  3. Bergman PJ, et al. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogenic human tyrosinase: a phase 1 trail. Clin Cancer Res 2003 Apr; 9(4):1284-90.

  4. Marino DJ, et al. Evaluation of dogs with digit masses: 117 cases (1981 -1991). J Am Vet Med Assoc. 1995 Sep 15;207(6):726-8.

  5. O’Brien MG, et al. Treatment by digital amputation of subungual squamous cell carcinoma in dogs: 21 cases (1987 - 1988). J Am Vet Med Assoc. 1992 Sep1;201(5):759-61.

MVS Surgical Oncology Team

Click on a name below to read a biography of a team member:

< Back to Article Index | Top of Page

Contents of this article are copyright ©Michigan Veterinary Specialists 2006. The contents of this article are for informational use only and cannot be used for any other reason without written permission of Michigan Veterinary Specialists. Please consult your veterinarian regarding abnormal conditions your pet may have.

 


 Terms of Use